Published Date : Oct 03, 2019
Non-invasive and small patches that are worn on the skin can check the level of medication administered to a patient after matching it with the current clinical records. Researchers from Imperial College London have exhibited the procedure of supervising the altering concentration of antibiotics through use of micreneedles. It was a small-scale clinical evaluation conducted by the researchers.
The findings of the evaluation exhibit that the sensors allow real-time supervision of changes in the concentrations of antibiotic in human bodies. The tests give out results similar to those obtained through blood tests.
Biosensors Could also Offer More Personalized and Efficient Drugs to Outpatients
The research team believes that technology could be utilized in changing how patients affected by acute infections are treated. It shows how fast body of the patient exhausts the benefits of the medications that have been given to them. The scientists further opine that if the future testing and developments come out with flying colors and the technology successfully reaches clinics, then it could end up in cutting cost for National Health Service in UK. It is also expected to lessen infections that have become resistant to drugs over time and help in the overall improvement of treatment that is given to the patients suffering from life-threatening infections.
The researchers further state that biosensors are capable of diminishing the need for blood analysis and sampling. It could also make an offering of more personalized and efficient drug delivery system that might be able to deliver drugs for outpatients outside hospital settings.
This technology has been developed with the help of research that received funding from Lyon-based Fondation Merieux and National Institute for Health Research (NIHR). Volunteers who participated in this research were both recruited and trained at Imperial College Healthcare NHS Trust. It is expected that this work would be taken up for further research through National Centre for Antimicrobial Research and Optimisation (CAMO) at Imperial College.
Their findings of the study was published on The Lancet Digital Health.